FDA clears laser keratome for eye surgery:
This article was originally published in Clinica
Executive Summary
IntraLase, of Irvine, California, has received clearance from the US FDA to market its laser keratome for use in vision correction procedures such as laser in situ keratomileusis, where a corneal flap is created prior to surgery. The Femtosecond Laser Keratome is an alternative to mechanical blades and is designed to reduce intraocular pressure during the procedure and improve precision.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.